文献速递介入腹部DSACT

转移性肝肿瘤患者药物洗脱微球化疗栓塞术后肝脓肿形成的危险因素

Liver abscess after drug-eluting bead chemoembolization in patients with metastatic hepatic tumors.
PubMed 文献 · Br J Radiol · 2021-11-29

该回顾性研究分析了137例转移性肝肿瘤患者接受DEB-TACE治疗后的临床数据,肝脓肿发生率为每患者8.76%、每操作5.53%。单因素分析显示较大肿瘤最大径、1级动脉闭塞及术前3个月内全身化疗与肝脓肿形成相关,多因素分析仅术前3个月内全身化疗为独立危险因素(OR 5.49)。

要点

  • DEB-TACE治疗转移性肝肿瘤后肝脓肿发生率每患者8.76%、每操作5.53%。
  • 术前3个月内全身化疗是肝脓肿形成的独立危险因素(OR 5.49)。
  • 较大肿瘤最大径和1级动脉闭塞在单因素分析中与肝脓肿相关。

诊断标准与关键数值

  • 肝脓肿发生率:每患者8.76%,每操作5.53%。
  • 单因素分析:较大肿瘤最大径(p=0.004)、1级动脉闭塞(p<0.001)、术前3个月内全身化疗(p<0.001)与肝脓肿形成相关。
  • 多因素分析:术前3个月内全身化疗为独立危险因素(OR 5.49;95% CI 0.34-13.54;p<0.001)。

局限性

  • 单中心回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the incidence and risk factors for liver abscess formation after treatment with drug-eluting bead chemoembolization (DEB-TACE) in patients with metastatic hepatic tumors (MHT).

METHODS: The current study is a retrospective analysis of the clinical data of 137 patients with metastatic hepatic tumors who received DEB-TACE treatment in our institute (Union Hospital, Tongji Medical College, Huazhong University of Science and Technology) between June 2015 and September 2020. Patients were evaluated for the presence or absence of post-DEB-TACE liver abscess. Univariate and multivariate analyses were used to identify risk factors for liver abscess formation.

RESULTS: The incidence of liver abscess formation after the DEB-TACE procedure was 8.76% per patient and 5.53% per procedure. Univariate analysis showed that larger maximum tumor diameter (p = 0.004), Grade 1 artery occlusion (p < 0.001) and systemic chemotherapy within 3 months before the DEB-TACE procedure (p < 0.001) were all associated with liver abscess formation. However, only systemic chemotherapy within 3 months before the DEB-TACE procedure (OR 5.49; 95% CI 0.34-13.54; p < 0.001) was identified by multivariate analysis to be an independent risk factor.

CONCLUSIONS: Tumor size, Grade 1 artery occlusion and recent systemic chemotherapy may all be associated with increased risk of liver abscess formation following DEB-TACE treatment in patients with metastatic hepatic tumors.

ADVANCES IN KNOWLEDGE: Identification of risk factors for liver abscess formation following DEB-TACE in patients with MHT. These findings suggest the need for caution and consideration of the aforementioned risk factors on the part of interventional radiologists when designing DEB-TACE strategies and performing post-procedure patient management.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Ye, Zhu, Liu, et al. Liver abscess after drug-eluting bead chemoembolization in patients with metastatic hepatic tumors. Br J Radiol. 2021. PMID: 34762523. doi:10.1259/bjr.20211056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。